Gagarina A. Metabolic cardioprotectors tiotriasolin,cytochrom mildronat in treatment of cardias arrhytmias in patients with noncoronarogenic myocardial diseases.

Українська версія

Thesis for the degree of Candidate of Sciences (CSc)

State registration number

0401U001128

Thesis Registration Form

0401U001128.pdf

Applicant for

Specialization

  • 14.01.11 - Кардіологія

27-03-2001

Specialized Academic Board

К 52.600.01

Essay

On the basis of cytochemical study of principal pathways of intracellular energy metabolism and stu dy of cardiac arrhythmias by means of different me thods of ECG monitoring has been ahown that pa thologic alteration of energy metabolism is one of he crucial mechanisms of cardiac arrhythmias in pati- ents with non-coronarogenic myocardial diseases. Has been proved expedience and effectiveness of the using of metabolic cardioprotectors tiatriasolin, cytochrom and mildronat in treatment of cardiac arrhythmias studed in cohort of patients. Has been de- termined that application of above named metabolic cardioprotectors and combinations of themleads to normalization of energy metabolism and,thereby, produces strong stable antiarrhythmic effect in different forms of noncoronarogenic myocardial diseases

Read more

Similar theses

0524U000129

Oksana L. Rekovets

Сlinical and pathogenetic justification of individual diagnostic approaches and treatment programs in resistant arterial hypertension

0523U100016

Maslovskyi Valentyn Iuriyovych

Prognostic value of various clinical and instrumental markers and options for basic therapy to assess the quality of life and the nature of the course of myocardial infarction without elevation of the ST segment

0421U103208

Kovbasniuk Yuriy Vasylovych

Structure and functional myocardial changes and features of plasma hemostasis by patient with atrial fibrillation and different body mass index

0821U101742

Tanska Olha Oleksandrivna

Criteria for Patients to be Put on the Waiting List for Heart Transplantation

0821U101115

Kutia Inna Mykolaivna

Pathogenetic and prognostic value of vascular endothelial growth factor-A in acute myocardial infarction with the ST segment elevation